Literature DB >> 26272134

Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes.

Eva Ramboer1, Tamara Vanhaecke, Vera Rogiers, Mathieu Vinken.   

Abstract

The ubiquitous shortage of primary human hepatocytes has urged the scientific community to search for alternative cell sources, such as immortalized hepatic cell lines. Over the years, several human hepatic cell lines have been produced, whether or not using a combination of viral oncogenes and human telomerase reverse transcriptase protein. Conditional approaches for hepatocyte immortalization have also been established and allow generation of growth-controlled cell lines. A variety of immortalized human hepatocytes have already proven useful as tools for liver-based in vitro testing and fundamental research purposes. The present chapter describes currently applied immortalization strategies and provides an overview of the actually available immortalized human hepatic cell lines and their in vitro applications.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26272134      PMCID: PMC4579543          DOI: 10.1007/978-1-4939-2074-7_4

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  130 in total

1.  Cultivation and characterization of a new immortalized human hepatocyte cell line, HepZ, for use in an artificial liver support system.

Authors:  A Werner; S Duvar; J Müthing; H Büntemeyer; U Kahmann; H Lünsdorf; J Lehmann
Journal:  Ann N Y Acad Sci       Date:  1999-06-18       Impact factor: 5.691

2.  Active expression of p21 facilitates differentiation of immortalized human hepatocytes.

Authors:  N Kobayashi; T Kunieda; M Sakaguchi; T Okitsu; T Totsugawa; M Maruyama; Y Kosaka; M Takesue; N Shibata; N Tanaka
Journal:  Transplant Proc       Date:  2003-02       Impact factor: 1.066

3.  Specific interaction of polypyrimidine tract-binding protein with the extreme 3'-terminal structure of the hepatitis C virus genome, the 3'X.

Authors:  K Tsuchihara; T Tanaka; M Hijikata; S Kuge; H Toyoda; A Nomoto; N Yamamoto; K Shimotohno
Journal:  J Virol       Date:  1997-09       Impact factor: 5.103

4.  Epidermal growth factor- and hepatocyte growth factor-receptor activity in serum-free cultures of human hepatocytes.

Authors:  D M Runge; D Runge; K Dorko; L A Pisarov; K Leckel; V E Kostrubsky; D Thomas; S C Strom; G K Michalopoulos
Journal:  J Hepatol       Date:  1999-02       Impact factor: 25.083

5.  Hepatitis C virus genotype 1a growth and induction of autophagy.

Authors:  Malika Ait-Goughoulte; Tatsuo Kanda; Keith Meyer; Jan S Ryerse; Ratna B Ray; Ranjit Ray
Journal:  J Virol       Date:  2007-12-12       Impact factor: 5.103

6.  Establishment of immortalized human hepatic stellate scavenger cells to develop bioartificial livers.

Authors:  Takamasa Watanabe; Norikuni Shibata; Karen A Westerman; Teru Okitsu; Jean E Allain; Masakiyo Sakaguchi; Toshinori Totsugawa; Masanobu Maruyama; Toshihisa Matsumura; Hirofumi Noguchi; Shinichiro Yamamoto; Masaki Hikida; Akira Ohmori; Michael Reth; Anne Weber; Noriaki Tanaka; Philippe Leboulch; Naoya Kobayashi
Journal:  Transplantation       Date:  2003-06-15       Impact factor: 4.939

7.  Hawthorn (Crataegus oxyacantha L.) bark extract regulates antioxidant response element (ARE)-mediated enzyme expression via Nrf2 pathway activation in normal hepatocyte cell line.

Authors:  Violetta Krajka-Kuźniak; Jarosław Paluszczak; Jan Oszmiański; Wanda Baer-Dubowska
Journal:  Phytother Res       Date:  2013-07-10       Impact factor: 5.878

8.  Suppression of AKT anti-apoptotic signaling by a novel drug candidate results in growth arrest and apoptosis of hepatocellular carcinoma cells.

Authors:  Andrea Cuconati; Courtney Mills; Cally Goddard; Xianchao Zhang; Wenquan Yu; Haitao Guo; Xiaodong Xu; Timothy M Block
Journal:  PLoS One       Date:  2013-01-23       Impact factor: 3.240

9.  Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes.

Authors:  Tanja Deurholt; Niek P van Til; Aniska A Chhatta; Lysbeth ten Bloemendaal; Ruth Schwartlander; Catherine Payne; John N Plevris; Igor M Sauer; Robert Afm Chamuleau; Ronald Pj Oude Elferink; Jurgen Seppen; Ruurdtje Hoekstra
Journal:  BMC Biotechnol       Date:  2009-10-21       Impact factor: 2.563

10.  The cannabinoid Δ(9)-tetrahydrocannabivarin (THCV) ameliorates insulin sensitivity in two mouse models of obesity.

Authors:  E T Wargent; M S Zaibi; C Silvestri; D C Hislop; C J Stocker; C G Stott; G W Guy; M Duncan; V Di Marzo; M A Cawthorne
Journal:  Nutr Diabetes       Date:  2013-05-27       Impact factor: 5.097

View more
  11 in total

1.  Tubulin alpha 8 is expressed in hepatic stellate cells and is induced in transformed hepatocytes.

Authors:  Lisa Rein-Fischboeck; Rebekka Pohl; Elisabeth M Haberl; Sebastian Zimny; Maximilian Neumann; Kristina Eisinger; Thomas S Weiss; Sabrina Krautbauer; Christa Buechler
Journal:  Mol Cell Biochem       Date:  2017-01-07       Impact factor: 3.396

Review 2.  Liver regeneration biology: Implications for liver tumour therapies.

Authors:  Christopher Hadjittofi; Michael Feretis; Jack Martin; Simon Harper; Emmanuel Huguet
Journal:  World J Clin Oncol       Date:  2021-12-24

3.  Efficient Generation of Functional Hepatocytes from Human Induced Pluripotent Stem Cells for Disease Modeling and Disease Gene Discovery.

Authors:  Satish Kumar; Joanne E Curran; Sarah Williams-Blangero; John Blangero
Journal:  Methods Mol Biol       Date:  2022

4.  Analysis of reproducibility and robustness of a human microfluidic four-cell liver acinus microphysiology system (LAMPS).

Authors:  Courtney Sakolish; Celeste E Reese; Yu-Syuan Luo; Alan Valdiviezo; Mark E Schurdak; Albert Gough; D Lansing Taylor; Weihsueh A Chiu; Lawrence A Vernetti; Ivan Rusyn
Journal:  Toxicology       Date:  2020-12-08       Impact factor: 4.221

Review 5.  HBV-related hepatocarcinogenesis: the role of signalling pathways and innovative ex vivo research models.

Authors:  Joseph Torresi; Bang Manh Tran; Dale Christiansen; Linda Earnest-Silveira; Renate Hilda Marianne Schwab; Elizabeth Vincan
Journal:  BMC Cancer       Date:  2019-07-18       Impact factor: 4.430

Review 6.  Three-dimensional (3D) liver cell models - a tool for bridging the gap between animal studies and clinical trials when screening liver accumulation and toxicity of nanobiomaterials.

Authors:  Melissa Anne Tutty; Dania Movia; Adriele Prina-Mello
Journal:  Drug Deliv Transl Res       Date:  2022-05-04       Impact factor: 5.671

7.  Hepatic Models in Precision Medicine: An African Perspective on Pharmacovigilance.

Authors:  Tracey Hurrell; Jerolen Naidoo; Janine Scholefield
Journal:  Front Genet       Date:  2022-04-14       Impact factor: 4.772

Review 8.  Multicellular In vitro Models of Cardiac Arrhythmias: Focus on Atrial Fibrillation.

Authors:  Pim R R van Gorp; Serge A Trines; Daniël A Pijnappels; Antoine A F de Vries
Journal:  Front Cardiovasc Med       Date:  2020-03-31

Review 9.  Current Perspective: 3D Spheroid Models Utilizing Human-Based Cells for Investigating Metabolism-Dependent Drug-Induced Liver Injury.

Authors:  Christopher R Cox; Stephen Lynch; Christopher Goldring; Parveen Sharma
Journal:  Front Med Technol       Date:  2020-11-30

Review 10.  Mapping oncogenic protein interactions for precision medicine.

Authors:  Mehdi Sharifi Tabar; Habib Francis; Dannel Yeo; Charles G Bailey; John E J Rasko
Journal:  Int J Cancer       Date:  2022-02-14       Impact factor: 7.316

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.